Jpmorgan Chase & CO Ani Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 213,981 shares of ANIP stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,981

Previous 232,190 7.84%

Holding current value

$12.3 Million

Previous $16.1 Million 15.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$58.53 - $68.82 $1.07 Million - $1.25 Million	-18,209 Reduced 7.84%	213,981 $13.6 Million
Q1 2024 May 10, 2024	BUY	$54.2 - $69.69 $442,651 - $569,158	8,167 Added 3.65%	232,190 $16.1 Million
Q4 2023 Feb 12, 2024	BUY	$48.72 - $65.43 $6.34 Million - $8.52 Million	130,210 Added 138.8%	224,023 $12.4 Million
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $130,778 - $168,050	2,601 Added 2.85%	93,813 $5.45 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $1.78 Million - $2.57 Million	47,673 Added 109.49%	91,212 $4.91 Million
Q1 2023 May 18, 2023	BUY	$37.61 - $45.72 $367,186 - $446,364	9,763 Added 28.91%	43,539 $1.73 Million
Q1 2023 May 11, 2023	SELL	$37.61 - $45.72 $200,686 - $243,961	-5,336 Reduced 13.64%	33,776 $1.34 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $113,085 - $148,712	3,545 Added 9.97%	39,112 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $4,653 - $5,929	156 Added 0.44%	35,567 $1.14 Million
Q2 2022 Aug 11, 2022	BUY	$23.09 - $33.46 $163,407 - $236,796	7,077 Added 24.98%	35,411 $1.05 Million
Q1 2022 May 11, 2022	SELL	$26.91 - $47.15 $102,607 - $179,782	-3,813 Reduced 11.86%	28,334 $796,000
Q4 2021 Feb 10, 2022	SELL	$32.97 - $56.85 $94,986 - $163,784	-2,881 Reduced 8.22%	32,147 $1.48 Million
Q3 2021 Nov 12, 2021	BUY	$26.48 - $35.99 $927,541 - $1.26 Million	35,028 New	35,028 $1.15 Million

Others Institutions Holding ANIP

# of Institutions

203

Shares Held

15.3M

Call Options Held

24K

Put Options Held

7.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $999M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ani Pharmaceuticals Inc Transaction History